(Q46095786)

19 December 2017

title

Modafinil for the treatment of fatigue in lung cancer: a pilot study (English)

1 reference

19 December 2017

1 reference

A Spathis

1

1 reference

19 December 2017

R Dhillan

2

1 reference

19 December 2017

D Booden

3

1 reference

19 December 2017

K Forbes

4

1 reference

19 December 2017

K Vrotsou

5

1 reference

19 December 2017

K Fife

6

1 reference

19 December 2017

language of work or name

1 reference

6 March 2009

1 reference

19 December 2017

published in

Palliative Medicine

1 reference

19 December 2017

volume

23

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

325-331

1 reference

19 December 2017

Side effects expected and experienced by women receiving chemotherapy for breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. II. Effects on two nights of recovery sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

An evaluation of the abuse potential of modafinil using methylphenidate as a reference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Effects of modafinil on cognitive and meta-cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Modafinil: a gift to portmanteau

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Development of a fatigue scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309102614

21 January 2018

Identifiers

DOI

10.1177/0269216309102614

1 reference

19 December 2017

PubMed ID

19270033

1 reference

19 December 2017